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Background: Schmallenberg virus (SBV) was first detected in November 2011 in Germany and then rapidly spread
throughout Europe. In beef suckler farms, clinical signs are mainly associated with reproductive disorders,
particularly in late gestation, and intransient and non-specific symptoms, namely diarrhea, inappetence and fever.
The objectives of this study were to develop models that simulate the production of different beef suckler systems
in the United Kingdom (UK) and France and to use these models to estimate, through partial budget analyses, the
farm-level economic cost of SBV under two disease impact scenarios, namely high and low impact. The probability
for a farm to be in the high or low scenario depends, among other, on the high, low or nil vectorial activity for a
given period and location and on the period(s) of sensitivity of the animals to the disease.
Results: Under the high impact scenario, the estimated SBV impact ranged from 26€ to 43€ per cow per year in
France and from 29€ to 36€ per cow per year in the UK. It was approximately half of this amount in the low impact
scenario. These financial impacts represent 5 to 16% of the gross margin, depending on the country, impact
scenario and livestock system considered. Most of the SBV impact originates from the costs of the steers and
heifers not produced. Differences identified between the systems studied mainly stem from differences among the
value of the steers or heifers sold: SBV impact is higher for British autumn calving systems compared to spring
calving, and for French farms with calving and fattening activities compared to farms with only a single, annual
calving activity.
Conclusions: This study shows the usefulness of integrated production and economic models to accurately
evaluate the costs of diseases and understand which factors have major impacts in the different systems. The
models stand as a useful basis for animal health professionals when considering alternative disease control
measures. They are also a farm accounting tool for estimating disease impact on differing production practices,
which creates the necessary basis for cost-effectiveness analysis of intervention strategies, such as vaccination.
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Schmallenberg virus (SBV) was first detected in November
2011 in Germany [1]. It affects ruminant animals and
appears mainly transmitted by insect vectors of the
Culicoides spp. group and vertically in utero [2-4]. A
transmission by bull semen was also recently observed [5].
Following expansive spread in various European countries,
the virus was officially declared endemic in Belgium,
France, Germany, Italy, Luxembourg, the Netherlands,
Spain, Switzerland and the United Kingdom (UK) by the
end of May 2012. In beef suckler farms, clinical signs are
mainly associated with reproductive disorders. Depending
on the time of infection, abortion, stillborn animals, pre-
mature deliveries and various intra-uterine congenital
malformations may occur [6,7]. Schmallenberg virus has
been detected in malformed foetuses, stillborn lambs or
lambs born at term but with signs of neurological disor-
ders, such as blindness, deafness, recumbency, an inability
to suck and convulsions [7,8]. In adult cows, the acute
infection can result in transient and non-specific
symptoms, like diarrhea, inappetence, fever, and a reduc-
tion in milk yield, usually followed by a full recovery [1,9].
Such acute infections cause production losses in terms
of animals and milk yield and require additional expendi-
tures for palliative treatment of affected animals. Trade or
movement regulations may be a further economic cost for
farmers, because of immobilisation on infected animals
and extra costs due to specific export requirements to
SBV-free countries.
In order for beef producers to make an informed
decision on a potential intervention investment to control a
disease like SBV, it is essential to understand the trade-off
between intervention costs and disease losses that can be
avoided. This depends on the type of production system
which in turn determines the characteristics of outputs and
inputs and is associated with specific management deci-
sions that rule reproduction and/or replacement decisions.
Moreover it is linked to husbandry practices that influence
the magnitude of losses and expenditures associated with
disease. Thus, economic impact is determined with more
accuracy when production systems are accounted for and
when the production factors that cause the highest costs
related to disease can be identified. Since France and the
UK have herds of 3.9 and 1.5 million beef cows, respect-
ively, and together account for 45% of the European beef
cow herd, they are the focus of the present study.
The purpose of this work was to estimate the economic
impact of SBV at farm-level for the most common beef
suckler production systems of the UK and France. The
objectives were 1) to develop beef suckler production
models and define associated gross margins, 2) to calculate
the partial budget for SBV in the UK and France, and 3) to
investigate potential differences in model variables and
disease estimates between the two countries.Methods
Overview
For this research, the most typical beef suckler production
systems in the UK and France were identified. They were
modelled in Microsoft Excel to simulate the within-farm
population dynamics and to estimate the annual gross
margin (a measure of profitability) of each system. The
annual gross margins obtained were compared with the
respective published gross margins for validation
purposes. Schmallenberg disease parameters were
then included in the production models. A partial
budget analysis was used to compare the extra costs
and benefits of farm-level infections. Partial budget
analyses included new costs, revenue foregone, costs saved
and new revenue due to SBV. Values for the disease
parameters were obtained from existing literature and
by expert opinion consultation. Sensitivity analyses
were conducted to assess the variability of the disease
impact for different combinations of disease parameter
values. Details on the method can be found elsewhere
(Häsler B., Alarcon P., Raboisson D., Waret-Szkuta A.,
Rushton J., unpublished observations).
Beef suckler production models
Available benchmarking data and expert opinion were
used to identify the most common and representative
beef suckler systems in the UK and France. In total, four
production systems were identified for the UK and five
for France (Additional file 1: Table S1).
For the UK, the systems were differentiated based on
the geographic location (less favoured areas being
upland vs lowland) and the calving season (spring vs
autumn) and labelled taking into account these two
factors (e.g. ‘lowland_spring’ for lowland systems with
spring calving). In France, systems were based on the
link between breed, area and husbandry practices. The
Charolais, Limousin and Salers systems are located in
Massif Central (centre of France) while the Blonde
d’Aquitaine systems are in the South of France. All
four systems represent farms specialised in calving
activity (coded as Charolais_Calving, Limousin_Calving,
Salers_Calving and Blonde_Calving), i.e. they sell six to
10-month-old weaned non-fattened calves for fattening
(mostly to Italy). The fifth beef suckler model represents
the Charolais calving and fattening farms (coded as
Charolais_Fattening) in north-west France. In all systems,
first calving mainly occurs at three years old, pasture
(grass) is used in summer and cattle are housed in barns
during winter. All the males and females are sold, except
some females which are kept for replacement (i.e.
they are raised on the farm until first calving). The
Charolais_Calving and Limousin_Calving match the UK
beef lowland spring calving model. The Salers_Calving
matches the UK beef suckler upland spring calving model
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autumn calving model.
The production models simulated a one year production
cycle by quantifying the different animal inputs and
outputs (e.g. number of steers sold, number of heifers
replaced, etc.). Benchmarking data from different
independent sources based on farm surveys and actual
expenditures made by farmers were used for both the UK
[10-14] and France [14]. These publications were comple-
mented by other sources such as the authors’ expertise
and published statistics on market prices as required.
For example, to disaggregate feed costs in France by
the different class of animals the authors’ professional
judgment was necessary as data were solely available
for the whole farm. Production models included (i)
revenue from sales of heifers and steers, (ii) replacement
costs, (iii) feeding costs, (iv) veterinary and medicine
costs and (v) other variable costs, such as bedding costs
(Additional file 1: Table S2). Key differences between the
French and British systems were as follows: heifers are
commonly purchased in the UK whereas, in France, theyTable 1 Economic impact (in €) of Schmallenberg virus (SBV)
Additional expenditure Veterinary assistance on cows that have dystocia du
Treatment of cows that need caesarean due to SBV
Treatment of cows that have clinical SBV episodes
Treatment of cows that have aborted due to SBV
SBV testing of aborted foetuses, stillborn or malform
Cost of purchasing and raising heifers for replacem




Expenditure saved Concentrate feed saved on steers and heifers not p







Extra revenue Revenue from cows culled due to SBV abortion
Sum of benefits
NET TOTAL SBV COST (€)/HERD
NET TOTAL SBV COST (€)/COW
Range of plausible values (€/cow)
Ranges of plausible values are defined with minimum and maximal parameters, as
HI, high impact disease scenario; LI, low impact disease scenario.are raised on-farm; disposal costs are paid by a tax at
slaughter in France, but by farmers in the UK; the
cost of forages used for calves in France is relevant,
because some French farmers sell heavy 12–18 month
old calves directly to slaughterhouse (an uncommon
practice in the UK).
Estimation of annual gross margins
The production models were used to estimate the annual
gross margin for the different production systems (1):
Grossmargin ¼ Revenue−Replacement costsand breeding depreciation
−Feed costs−Veterinarycosts−other variable costs
ð1Þ
The revenue and costs calculated are listed in Table 1.
Details of calculations are reported in Additional file 1:
Table S2. All data used for the development of production
models and gross margin analyses are listed in the
Additional file 1: Tables S3 and S4. The economic datafor three types of beef suckler farms in France
Charolais Calving Salers Calving Charolais Fattening
HI LI HI LI HI LI
e to SBV 73 37 75 38 73 37
dystocia 7 3 7 3 7 3
26 0 26 0 26 0
60 30 60 30 60 30
ed calves 1 0 1 0 1 0
ent 75 38 126 63 76 38
1,810 910 1,548 778 2,533 1,273
1,866 937 1,657 832 2,693 1,353
44 22 46 23 44 22
3,961 1,977 3,546 1,769 5,512 2,757
roduced 256 137 453 228 512 261
led 54 27 43 22 54 27
162 81 63 32 194 97
117 59 72 36 153 77
1 1 1 1 1 1
58 29 59 29 58 29
1 1 1 1 4 2
5 3 5 5 5 3
230 115 160 80 200 100
884 451 857 442 1,181 595
3,077 1,526 2,689 1,347 4,256 2,162
30.7 15.3 26.9 13.5 42.5 21.6
8-99 0-14 7-84 0-15 11-135 0-22
listed in Table 2.
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authors judgment when no data was available.
Assessment of SBV disease impact using partial budget
models
First, on the basis of a literature review, the biological
effects of SBV in beef suckler cattle were identified (Table 2).
Further, common management practices were discussed
and assumptions made regarding farmers’ reactions to
disease without considering labour (Additional file 1:
Table S5). For instance, it was assumed that SBV will
result in extra culling because farmers will not use animals
with reproductive disorders for breeding again. Although
there are anecdotal reports that SBV may cause infertility
in cows, there is no robust scientific evidence available yet
about such effects so infertility problems were excluded
from this study. The diversity of factors involved in infertil-






Number of calves stillborn or








Number of cows with dystocia out of
100 cows giving birth to a stillborn or
malformed calf due to SBV
30 [16
exp
Number of cows that need caesarean
out of 100 cows with dystocia due to SBV
5-7 most likely = 6 [18
opi
Number of cows with clinical episodes





Number of cows that require treatment
out of 100 cows with clinical episodes
due to SBV
10 Exp
Number of cows with SBV abortions out






Probability of an aborted foetuses,
stillborn, malformed and calves
culled to be tested for SBV
0.05 Exp
Number of cows that die due to calving
difficulties out of 100 cows with dystocia
10 [17
opi
Number of aborted cows that will need
to be replaced out of 100 cows with
abortions
10 Expa causal effect of SBV infection. Second, the disease param-
eters were introduced in the production models. The differ-
ences obtained between gross margin parameters of disease
and no disease situations were calculated. For example, the
proportion of abortions due to SBV changed the number
of calves born, which then resulted in lower revenue from
calves sold. For new cost items, new parameters were
created in the model, such as “cost of caesarean” (number
of caesarean * costs of one caesarean) or “cost of SBV
testing” (number of foetuses tested * cost of one SBV test).
Finally, the differences of the gross margin were compared
using a partial budget analyses (2):
Net SBV economic costi ¼ Costs savedi þ Newrevenueið Þ
− Newcostsi þ Revenue forgoneið Þ
ð2Þ
Net SBV economic cost represents the economic impact




Martinelle et al. 2012 [15]: median SBV morbidity rate in
calves was 2% ; the minimum reported by Martinelle et al.
[15] was taken as the lower range value and the median
value plus one standard deviation as the upper range value.
,17] and
ert opinion
Baseline dystocia rates in UK are 6.9% in heifers and 2%
in cows with abnormal presentations being the cause in
19.8% on average. With an increased proportion of
malformations, dystocia rate was assumed to be higher.
,19] and expert
nion
The proportion of caesareans conducted in the case of
dystocia was reported to be between 5 and 7%.
] and expert
nion
Martinelle et al. 2012 [15]: Median SBV morbidity rate in
cattle was 7.5%. The minimum reported by Martinelle et al.
[15] was taken as the lower range value and the median
value plus one standard deviation as the upper range value.
ert opinion This figure reflects the regular need for treatment of
beef sucklers in the UK presented with unspecific
diarrhoea, fever, general depression and/or inappetence.
ert opinion The proportion of abortions due to SBV is uncertain
(lack of studies). Experts agreed on these approximated
figures based on abortion rates seen in other diseases.
ert opinion Investigation of abortions is recommended if incidence
>3% in a herd per year or if several abortions occur in
quick succession (http://www.defra.gov.uk/ahvla-en/files/
pub-cattle-abortion.pdf). Due to the absence of “abortion
storms” due to SBV and farmers suspecting the disease,
it is assumed that only a small proportion submit




Day and Meijering report mortality rate due to dystocia
as 3.5% on average, and 16.7% for a clinical case
observation. Given that SBV causes malformations, the
mortality rate is assumed to be on higher than the
reported average.
ert opinion It was assumed that only in a small proportion of cows
the reproductive system will be affected such that the
cow is not able to breed anymore and will therefore be
replaced.
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of various disease effects (e.g. rate of abortion, percentage
of cows with clinical signs) and the magnitude of those
effects or consequences (e.g. proportion of cows with
dystocia that will need caesarean) are sparse but sufficient
to consider two impact scenarios:
 Scenario 1: High impact in a herd that is highly
susceptible to disease, which may be for example a
management system where the susceptible gestation
period falls into a season of high vector activity.
 Scenario 2: Low impact in a herd that is less
susceptible to disease, which may be for example a
management system in an area with low vector
density or where the gestation period falls into a
season with low vector activity.
For each scenario, input parameters were defined as
summarised in Table 2 to calculate the partial budget. In
addition to the values derived from the scientific literature,
the input values for the model were discussed and agreed
on during an expert workshop as described below. For the
most variable and uncertain parameters, minimum, most
likely and maximum values were agreed upon. In brief,
the three parameters that differed between the high and
low impact scenario were (i) the percentage of stillborn
and malformed calves, (ii) the percentage of cows with
clinical episodes due to SBV and (iii) the percentage of
cows with abortion (Table 2).
Software, input values, sensitivity analysis, and validation
All models were developed and run in Microsoft Excel
2010 (Microsoft Corporation). Apart from the parameter
values derived from published literature, a workshop
with 10 experts representing members of the Schmallenberg
surveillance team at the Animal Health Veterinary
Laboratories Agency, industry representatives, veterinary
clinicians and academic researchers was held to present
and discuss the structure of the production models, input
variables and assumptions. Before the meeting experts
were requested to give their opinion on the values of
some of the disease parameter for high and low impact
scenarios. The different values obtained were then
presented to the experts during the workshop. For
those parameters with major differences a discussion
was stimulated to agree on the value. Annual gross
margins obtained were compared with the respective
published gross margins for validation purposes. The
sensitivity of the model to a simultaneous change of
the variable percentage of stillborn and malformed
calves due to SBV and the variable percentage of
cows with late abortions due to SBV was tested by
changing their values from 0 to 5% and from 0 to 3.5%
respectively, as these two parameters were defined as themost important disease factors by the workshop partici-
pants. The models were also run with all lowest and all
highest values to estimate the range of disease impact.
For purpose of comparison and clarity, all economic
results are presented in euros (1€ = £0.8128, as consulted
on the 20th of May 2014).
Results
Production models and gross margin
Summary results of the gross margin analyses are
presented in Figures 1 and 2. The detailed structure and
results of the Charolais_Calving production models and
gross margin analyses of non SBV-infected farms are
presented in Additional file 2: Tables S1 and S2.
In France, the model gross margins obtained for
Charolais_Calving, Limousin_Calving, Blonde_Calving,
Salers_Calving and Charolais_Fattening were 293€,
253€, 307€, 209€ and 329€ per cow per year, respectively
(Figure 1). The lower gross margin observed for
Salers_Calving is due to the reduced revenue, and the
higher gross margin observed for Charolais_Fattening is
due to higher revenue in spite of higher feeding costs
(Figure 2). All results match the reference ones, except a
33% lower gross margin in the present study compared to
reference for Charolais_Calving. The sum of production
costs is in the same range, and the difference mainly
originates from the feeding cost.
For the UK, the model gross margin obtained for
Lowland_autumn, Lowland_spring, LessFavoured_Autumn
and LessFavoured_Spring were 281€, 173€, 297€ and
184€ per cow per year, respectively (Figure 1). The
main differences observed in Lowland_autumn and
LessFavoured_Autumn between the model gross margin
and the industry gross margin as calculated by the
industry (Business pointer 2012), are due to the estimation
of revenue from selling calves (Figure 2). The difference
in revenue is mainly caused by the way calf weight is esti-
mated. The main differences observed in Lowland_Spring
and LessFavoured_Spring between the model gross mar-
gin and the industry gross margin are explained by the
forage cost estimation.
Impact of SBV
The net SBV economic cost of SBV (in €/cow/year)
for an average French beef suckler farm was esti-
mated at 30.7€ and 15.3€ for Charolais_Calving farms,
30.1€ and 14.5€ for Limousin_Calving farms, 31.9€
and 15.4€ for Blonde_Calving farms, 26.9€ and 13.5€
for Salers_Calving farms, and 42.5€ and 21.6€ for
Charolais_Fattening, for the high and low impact sce-
nario, respectively (Table 1). Results of Limousin_
Calving and Blonde_Calving are very close to that of
Charolais_Calving, so only those for Charolais_Calving are







































Farm management book 2013
(John Nix)












Figure 1 Gross margin results for SBV free beef suckler farms in France (up) and in the UK (down) and comparison with other gross
margin analyses existent in the literature. Institut Elevage, bovin viande (2013) = [14]; Farm management book 2013 = [11]; Budgeting and
Costing 2012 = [12]; Farm management handbook 2010 = [10]; Business pointer 2012 = [13].
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costs), whatever the system and the scenario (high or low
impact).
For the UK, the net SBV economic cost (in €/cow/
year) for an average farm was estimated at 34.8€
and 17.5€ for Lowland_Autumn farms, 29.3€ and
14.7€ for Lowland_Spring farms, 36.4€ and 18.3€
for LessFavoured_Autumn farms and 30.0€ and 15.0€ for
LessFavoured_Spring farms, for the high and low impact
scenario, respectively (Table 3). For France, the new costs
and revenue foregone accrued mainly from the revenue
foregone from steers and heifers not sold, regardless
of the system and scenario (over two thirds of the
sum of costs).
Sensitivity analyses were performed for two of the
most sensitive and uncertain disease parameters. The
variations of the net SBV economic cost obtained during
these sensitive analyses are illustrated in Additional file 2:
Table S3. The range from the best case (using minimum
values for all disease inputs as defined in Table 2) to the
worst case (using maximum values for all disease inputs
as defined in Table 2) for the low and high impact
scenario are reported in Tables 1 and 3 (in the row
of ‘range of plausible values’). Results of the sensitivity
analyses and the range found from best to worse case ofLimousin_Calving and Blonde_Calving are very close
to those of Charolais_Calving for which details are
provided here. Similarly, sensitivity analyses and
ranges from best to worse case of Lowland_Autumn
and LessFavoured_Autumn were close, as were results
for Lowland_Spring and LessFavoured_Spring.
Comparison of gross margins with and without SBV
The impact of SBV on the farm gross margins is shown
in Figure 3. The figures illustrate the gross margin
expressed as € per cow per year, respectively, for a farm
not infected with SBV, highly affected and slightly
affected. The reductions in gross margins for the high
impact scenario are 10% in Charolais_Calving farms (FR)
and Blonde_Calving farms (FR), 12% in Limousin_Calving
farms (FR), in Lowland_Autumn farms (UK) and in
LessFavoured_Autumn farms (UK), 13% in Salers_Calving
(FR) and Charolais_Fattening (FR) farms and 16% in
Lowland_Spring farms (UK) and LessFavoured_Spring
(UK) farms. Percentages are reduced by two fold in
the low impact scenarios.
Discussion
The present study used partial budget and gross margin
analyses in combination with production models to
Figure 2 Break down of the gross margin for SBV free 5 types of beef suckler production systems in France (up) and for 4 types of
beef suckler production systems in the UK (down). JN13 = John Nix 2013 = [11]; BCB12 = Budgeting and Costing Book 2012 [12]; BP12 =
Business pointer 2012 = [13]; FMH2010 = Farm management handbook 2010 = [10].
Raboisson et al. BMC Veterinary Research 2014, 10:254 Page 7 of 11
http://www.biomedcentral.com/1746-6148/10/254estimate the economic impact of SBV in different beef
suckler livestock system. The main advantage of combining
production models and partial budget analysis is that it
exposes the cascade effect that the disease may have on the
production and the farm performances (e.g. extra dystocia
caused because of stillborn or malformed calves due
to SBV). Although the time frame chosen for this study
was one year, the modelling approach complements the
dynamic population of the herd and allows a precise
quantification of performance changes that would not be
possible through a partial budget analysis alone [20,21].
Moreover, the calculation of the gross margin in the
production model allows a direct validation of the
model with benchmarking data and therefore provides
a solid foundation for disease impact studies. The use
of gross margin analysis also proved useful to understand
the impact of the disease on the profitability of each
system. However, the models do not take into account the
medium or long term consequences of the SBV infection.Such predictions could be made by inclusion of behaviour
assumptions in the models (e.g. on variation in manage-
ment over time), predictions on price developments and,
most importantly, the epidemiology of the disease and
related effects. While a farm’s replacement policy may
change in the long term, the beef industry is mainly
focused on the production of one calf per year per
cow and it is therefore intuitive to estimate the disease
consequences for a one year production cycle. Most of the
carry-over effects to the next following year(s) were
integrated within the studied one-year cycle period, in
particular for extra culling and extra replacement.
Similarly mortalities or abortions during the studied
year for animals that would have been sold in the follow-
ing year in case of no disease were accounted for in the
studied year.
For France, the disease impact is similar for the three
main systems (Charolais_Calving, Limousin_Calving and
Blonde_Calving), slightly lower for Salers_Calving and
Table 3 Economic impact of Schmallenberg virus (SBV) for the 4 types of beef suckler farms in the UK




HI LI HI LI HI LI HI LI
Additional
expenditure
Veterinary assistance on cows that have
dystocia due to SBV
60 32 64 32 64 32 64 32
Treatment of cows that need caesarean
due to SBV dystocia
7 4 7 4 7 4 7 4
Treatment of cows that have clinical SBV
episodes
10 0 10 0 10 0 10 0
Treatment of cows that have aborted
due to SBV
255 127 255 127 255 127 255 127
SBV testing of aborted foetuses, stillborn or
malformed calves
1 1 1 1 1 1 1 1
Cost of purchasing and raising heifers for
replacement
421 212 421 145 449 140 449 140
Disposal costs of dead calves and foetus
due to SBV
285 145 289 212 279 225 279 225
Revenue forgone Steers not sold 1,578 771 1,168 587 1,583 796 1,209 608
Heifers not sold 1,393 700 1,085 545 1,452 730 1,122 563
Cows that die 33 18 36 18 36 18 36 18
Sum of costs 4,001 2,009 3,334 1,670 4,135 2,319 3,431 1,719
Expenditure saved Concentrate feed saved on steers and
heifers not produced
109 55 54 27 117 59 74 37
Concentrate feed saved on cows that
die or are culled
84 42 54 27 64 32 54 27
Bulk feed saved 49 25 44 22 20 10 39 20
Forage saved on cows culled 0 0 0 0 0 0 0 0
Bedding costs saved 89 44 78 39 122 62 108 54
Miscellaneous costs saved 47 23 39 20 47 23 39 20
Cow vaccines saved 0 0 0 0 0 0 0 0
Calf vaccines saved 5 2 5 2 5 2 5 2
Cow worming saved 0 0 0 0 0 0 0 0
Calf worming saved 0 0 0 0 0 0 0 0
Extra revenue Revenue from cows culled due
to SBV abortion
132 64 129 64 116 58 116 58
Sum of benefits 514 256 405 201 491 242 436 215
NET TOTAL SBV COST (€)/HERD 3,487 1,753 2,929 1,470 3,644 1,829 2,996 1,503
NET TOTAL SBV COST (€)/COW 34.9 17.5 29.3 14.7 36.4 18.3 30.0 15.0
Range of plausible values (€/cow) 9-106 0-17 7-89 0-15 10-109 0-18 7-90 0-15
Ranges of plausible values are defined with minimum and maximal parameters, as listed in Table 2.
HI, high impact disease scenario; LI, low impact disease scenario.
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the high or low impact scenario considered. For UK, the
results show a slightly increased impact of SBV for
autumn calving compared to spring calving in UK,
both for the low and high impact scenarios. This is mainly
attributable to the higher revenue usually obtained on
autumn calving from the calves sold. Thus, for both
countries, it was found that the higher the revenues
in the gross margin, the higher the SBV impact. Therevenue greatly depends on the selling prices of the
heifers and steers (which depend on breed, age of
selling and season of selling). The differences in SBV
impact between the different livestock systems mainly
come from the differences in revenues between the
systems. The fact that French Charolais_Fattening has
the higher SBV impact may originate from the period of
calving in autumn, as suggested by the higher impact in
UK for autumn calving systems as compared to spring
Figure 3 Gross margins (€/cow) for not SBV affected, highly and slightly SBV affected beef suckler farms in France (up) and in the
UK (down).
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fattening activity than to the calving period. The net
revenue per cow is higher when calves are fattened
compared to when weaned calves are sold, and the
loss of a calf due to SBV has consequently a higher
impact. Indeed, in all the systems considered, the
major SBV cost for a beef suckler farm is associated
with the losses due to steers and heifers that could
not be sold because of the disease. Yet, the SBV im-
pact estimation may have been overestimated for
Charolais_Calving since the present results account
for idle production capacity but farmers could replace
the lost weaned calves entering the fattening unit with
purchased ones. Other major costs in beef suckler
herds are those accrued from the cost of purchasing
replacement heifers (in UK and to a lesser extent, inFrance) and the disposal cost of dead or culled animals
(in UK only).
The difference between calculated and reference gross
margins observed for the French Charolais_Calving
system is due to the feeding costs. This difference
likely originates from the variability among farms
within (i) the age at weaning, (ii) the cost of feeding
cows and calves in barns (higher part of the year
compared to calving systems), and (iii) the distribution
of the feeding costs between forage and concentrates
(various indoor diets, with more or less forage and
concentrates). The farming systems yet remain ranked
according to the gross margin in the same way as in
the references used (lower gross margin for extensive
system, higher gross margin for fattening system). For
the autumn calving herds in the UK, the revenue
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estimates. In the present results and in accordance with
existing literature [11], it is considered that autumn
calving systems produced calves that are sold at much
higher weight (average 358 kg) than spring calving
systems (average 275 kg). The industry benchmarking
[13], do not differentiate autumn and spring calving
systems (average calf weight is 279 kg). In addition,
calf price used in the present model is in accordance
with [11] and is slightly higher than the one used by
the industry benchmarking [13]. Furthermore, industry
gross margins are higher due to lower forage cost, which
were not used to calculate impact of disease in this study.
Therefore, the production model developed is believed to
reflect the industry gross margin for the different beef
suckler systems.
One of the main limitations of this study was the lack
of data available in the literature on SBV disease effects,
which may be partly due to a lack of reporting and
the absence of incentives for reporting. Most of the
published scientific literature described the situation
on SBV affected farms, but only in some exceptional
cases compared them to non-affected farms or previous
years before SBV emergence. As a result, attribution
of disease estimates was not possible from those studies
so experimental or epidemiological studies comparing
affected and non-affected farms are needed to obtain more
accurate disease estimates. The disease estimates used in
this study were derived from scientific publications where
ever possible and complemented by expert opinion consult-
ation. Sensitivity analyses on disease estimates were used to
account for this uncertainty and demonstrate the influence
of the most uncertain input values used.
The present work estimates the net SBV economic costs
under French and British conditions, for nine production
systems and under two scenarios. The disease impact may
reach up to 5 to 17% of the gross margin in the worst case,
depending on the system, the country and the impact
scenario. SBV may consequently slightly change the
economic performance of some farms. The disease
impact differs more between livestock systems within
a country than between countries.
These results are of great interest for farmers and
veterinarians in field. They also may be useful for decision
makers as part of a decision making process. When using
the results, three considerations apply. First, the present
estimations represent the total cost of the SBV at
farm-level and not the avoidable costs. Thus, if seeking a
trade-off with the cost of vaccination, the current results
may be used but acknowledging the gap between total
costs and avoidable costs. The best way to evaluate such a
trade-off would be to perform an economic efficiency
analysis of possible SBV vaccination strategies, with
the efficacy and price of the vaccines known. Yet, becauseof the differences in institutional factors between the two
countries, such as veterinarian services or mean herd size,
the control of SBV may depend on different production
strategies in France and the UK, even if no noticeable
difference in SBV impact is observed between France and
the UK in the present work. Second, the present estima-
tions are made for a one year cycle, and may misrepresent
the medium or long term consequences of the SBV. Third,
the use of the present results to make a first, raw calcula-
tion of the national impact of SBV is possible by multiply-
ing the SBV impact (nil, low or high) by the number of
farms or cows concerned. Yet the set of possible situations
depends on (i) the high, low or nil vectorial activity for a
given period and location and (ii) on the period(s) of
sensitivity of the animals to the disease. For instance,
knowledge of the production system suggests that autumn
and early winter calving herds (i.e. UK autumn calving
systems and French Calving_Fattening) should be consid-
ered in the high impact scenario. On the contrary, the
spring calving systems are more likely to follow the results
of the low impact scenario, although the impact could be
nil if the period of mid-gestation is distinct from that of
vector activity (winter). Moreover, the impact is more
likely to be high for an infection of a SBV naïve herd
although it may remain low and perhaps nil in case
of re-infection in endemic situation. Information
regarding SBV immunity strength and duration is needed
to estimate the probability of high or low scenario
under endemic situation. Whatever the case, because
of the numerous situations regarding the vectorial
activity and cow infection characteristics, calculating
the national impact of SBV based on the current
work is possible (albeit challenging) and remains open
to further research.
Conclusions
For the high impact scenario, the net SBV economic cost
was estimated from 26€ to 43€ per cow per year in
France and from 28€ to 37€ per cow per year in the UK
(5% to 16% of the gross margin). It was half in the
case of the low impact scenario. High and low impact
scenarios might depend on the gestation period at
which infection occurs, the vector density in each system,
the immunity of the herd and other factors, such as breed.
Therefore farms with calving periods around autumn
might be more likely to be highly affected. Most of the
SBV impact originates from the costs related to the
sub-optimal performance of herds. Differences observed
between the systems studied mainly arise from the differ-
ences among the value of the steers or heifers sold. Even
though total SBV costs, but not unavoidable costs are esti-
mated here, the present work provides a useful basis to
evaluate the economic efficiency of SBV control measures
at farm-level.
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